InsidersTradesSigma
Follow the DXエンゲージメントパートナーズ合同会社 share price and the full management transaction log of the company, a listed equity based in Japan. Shares are listed on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, DXエンゲージメントパートナーズ合同会社 has published 7 public disclosures. Market capitalisation: €3.1bn. The latest transaction was disclosed on 8 November 2022 (Holding update). All data is accessible without an account.
Analysts rate DXエンゲージメントパートナーズ合同会社 Buy (bullish), based on 5 analysts. Average price target: US$14.75.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
DX Engagement Partners LLC is a company operating in the healthcare and pharmaceutical sector. It is listed on the XTKS market.